HR Execs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

American Ambulance

American Ambulance's corporate vision is comprised of our Mission Statement, Values and Quality Principles, and Client's Bill of Rights. These philosophies are used to guide American Ambulance now and into the future.

Giuseppe Space Enterprises

Giuseppe Space Enterprises is a company that specializes in the implementation, integration, and optimization of various tools and technologies into standardized system engineering/integration processes and workflows. They are committed to advancing th...

Educational Resource Systems

Educational Resource Systems is a Red Bank, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Texas Hip and Knee Ctr

Texas Hip & Knee Ctr is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

SoberRecovery

SoberRecovery is a San Juan Capistrano, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.